Societal Costs Associated With Pulmonary Arterial Hypertension Subgroups: A Study Utilizing Linked National Registries

Documenti analoghi

• Risk Assessment Models and Event‐Free Survival in Pulmonary Arterial Hypertension
  di: Clara Hjalmarsson, et al.
  Pubblicazione: (2025)
• Association of Immunoglobulin E With Right Ventricular Dysfunction in Pulmonary Arterial Hypertension
  di: Fengxia Wu, et al.
  Pubblicazione: (2026)
• Macitentan Plus Tadalafil Single‐Tablet Combination Therapy in Chinese Patients With Pulmonary Arterial Hypertension: A Subgroup Analysis of the A DUE Study
  di: Fenling Fan, et al.
  Pubblicazione: (2025)
• Prevalence and Economic Burden of Pulmonary Hypertension and Pulmonary Arterial Hypertension Among the Medicaid Population
  di: Marshaleen Henriques King, et al.
  Pubblicazione: (2025)
• Prognostic Role of Platelets in Pulmonary Arterial Hypertension
  di: Caio Julio Cesar dos Santos Fernandes, et al.
  Pubblicazione: (2025)